er the age of 65 involved three or more CNS-affecting drugs; the number jumped to 1.4 percent in 2013. If that percentage were applied to the entire U.S. post-65 population, it would mean 3.68 million doctor visits a year involving seniors taking three or more CNS drugs, up from about 1.5 million visits in 2